Prelaminar hyperreflective lines in non-arteritic anterior ischaemic optic neuropathy

• by Anas Alkhabaz, Bianca Chan, Yulan Ren, Rishita Rama Pujari, Jamie Zhang, Hugo Wu, Yaping Joyce Liao

• October 9, 2026

Shallow and bullous retinal pigment epithelium elevations in age-related macular degeneration

• by Jost B. Jonas, Songhomitra Panda-Jonas, Jie Xue, Rahul A. Jonas, Ya Xing Wang

• September 25, 2026

Spectacle Lenses With Highly Aspherical Lenslets for Myopia Control: A Randomized Clinical Trial

• by Jason Shen, Chris Hunt, Graeme Young, Björn Drobe

• October 1, 2026

FDA clears targeted cholangiocarcinoma therapy

In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.

• by Kathryn Wighton

• September 24, 2026

• 2 min